Researchers at NIAID have found that mouse immune systems produce antibodies capable of single-handedly neutralizing the SARS virus. This discovery confirms that vaccines triggering antibodies to the SARS virus are on the right track, and could lead to a faster development of effective vaccines or antiviral drugs.
Scientists capture real-time video-clips of signal transmission in living cells using Quantum Dots, revealing new insights into cellular processes. The breakthrough is expected to speed up the development of new cancer-curing drugs.
A Wistar Institute-led team will develop blood tests to detect early lung cancer using proteomics and genomics, aiming to save lives through earlier cancer detection. The project receives $3.4M in funding from Pennsylvania's share of the national tobacco settlement.
A study found that gefitinib is effective for patients with non-small cell lung cancer who are female, never smoked, and have a specific type of cancer. The researchers identified two key factors associated with sensitivity to the drug: having adenocarcinoma with bronchioloalveolar features and never having smoked.
The University of Hawaii has developed a mentoring relationship with the University of North Carolina School of Dentistry to address oral health disparities in Hawaii. The collaboration aims to improve the oral health status of the people of Hawaii by conducting pilot studies on mothers and their babies in rural communities.
Faslodex, a novel oestrogen receptor antagonist, has been approved by the EU for treating advanced oestrogen receptor-positive breast cancer. The drug offers durable responses and tolerability benefits compared to existing therapies, with a unique sustained release formulation administered monthly.
Research from Imperial College London finds that African cotton markets benefit from a balance between competition and coordination. The study reveals that concentrated, market-based systems have been successful in meeting common challenges while maintaining reasonable prices to consumers.
Novel genetic profiling can identify residual tumors and precancerous lesions, allowing for targeted treatment. Early clinical trials show promise for gene-mediated strategies to replace defective sequences and block signal transduction.
The demand for outpatient dental anesthesia and sedation services remains high despite a decline in training programs and an evidence-based foundation. Dr. Raymond Dionne calls for a scientific agenda to develop a safe and effective approach for dental outpatients.
A researcher is studying how diabetes affects ganglion cells and developing a potential treatment using sigma receptor ligands. The goal is to prevent ganglion cell death and the growth of new blood vessels that obstruct vision.
A new dental caries vaccine is being proposed as a crucial tool to prevent the spread of tooth decay, particularly in vulnerable populations. The symposium emphasizes the vaccine's potential to combat the disease and its impact on public health.